These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8273759)

  • 41. Outcome with implantable cardioverter-defibrillator therapy for survivors of ventricular fibrillation secondary to idiopathic dilated cardiomyopathy or coronary artery disease without myocardial infarction.
    Lessmeier TJ; Lehmann MH; Steinman RT; Fromm BS; Akhtar M; Calkins H; DiMarco JP; Epstein AE; Estes NA; Fogoros RN
    Am J Cardiol; 1993 Oct; 72(12):911-5. PubMed ID: 8213548
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The automatic implantable cardioverter-defibrillator for prevention of sudden heart death in children and adolescents].
    Paul T; Luhmer I; Trappe HJ; Klein H; Fieguth HG; Brauer C; Scharpwinkel U; Kallfelz HC
    Z Kardiol; 1993 Aug; 82(8):466-73. PubMed ID: 8212779
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Initial clinical results with a novel implantable cardioverter-defibrillator: a prospective evaluation in 3 Swiss university hospitals].
    Osswald S; Candinas R; Fuhrer J
    Schweiz Med Wochenschr; 1995 Dec; 125(50):2423-32. PubMed ID: 8553030
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Problems and complications after implantation of automatic defibrillators].
    Trappe HJ; Klein H; Fieguth HG; Wenzlaff P; Lichtlen PR
    Med Klin (Munich); 1993 Nov; 88(11):619-28. PubMed ID: 8295602
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Implantable transvenous cardioverter-defibrillators.
    Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D
    Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
    Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
    Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Implantable cardioverter-defibrillator in the elderly: Predictors of appropriate interventions and mortality at 12-month follow-up.
    Ferretto S; Zorzi A; Dalla Valle C; Migliore F; Leoni L; De Lazzari M; Corrado D; Iliceto S; Bertaglia E
    Pacing Clin Electrophysiol; 2017 Dec; 40(12):1368-1373. PubMed ID: 28994461
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors of outcome in patients with implantable transvenous cardioverter defibrillators.
    Tebbenjohanns J; Schumacher B; Jung W; Korte T; Pfeiffer D; Manz M; Lüderitz B
    Am Heart J; 1994 Apr; 127(4 Pt 2):1086-9. PubMed ID: 8160585
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Results of the international study of the implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead systems. The Pacemaker-Cardioverter-Defibrillator Investigators.
    Zipes DP; Roberts D
    Circulation; 1995 Jul; 92(1):59-65. PubMed ID: 7788918
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cost-effectiveness of implantable defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors. A randomized study.
    Wever EF; Hauer RN; Schrijvers G; van Capelle FJ; Tijssen JG; Crijns HJ; Algra A; Ramanna H; Bakker PF; Robles de Medina EO
    Circulation; 1996 Feb; 93(3):489-96. PubMed ID: 8565166
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The prospective study on the prognosis in patients with ventricular tachycardia or fibrillation treated with implantable automatic cardioverter defibrillator].
    Liu ZM; Guo T; Huang W; Han MH; Zhao L; Li SM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Apr; 36(4):309-12. PubMed ID: 19100005
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone.
    Gali WL; Sarabanda AV; Baggio JM; Ferreira LG; Gomes GG; Marin-Neto JA; Junqueira LF
    Europace; 2014 May; 16(5):674-80. PubMed ID: 24481778
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
    Anselme F; Moubarak G; Savouré A; Godin B; Borz B; Drouin-Garraud V; Gay A
    Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term clinical outcome in patients with severe left ventricular dysfunction and an implantable cardioverter-defibrillator after ventricular tachyarrhythmias.
    Pelicano N; Oliveira M; Da Silva N; Antunes E; Santos S; Conceição JM; Roquette J; Quininha J
    Rev Port Cardiol; 2005 Apr; 24(4):487-98. PubMed ID: 15977773
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication.
    Schaer B; Kühne M; Reichlin T; Osswald S; Sticherling C
    Europace; 2016 Feb; 18(2):227-31. PubMed ID: 26063686
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
    Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
    Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preventive effectiveness of implantable cardioverter defibrillator in reducing sudden cardiac death in the Chinese population: a multicenter trial of ICD therapy versus non-ICD therapy.
    Hua W; Niu H; Fan X; Ding L; Xu YZ; Wang J; Chen K; Wang F; Zhang S;
    J Cardiovasc Electrophysiol; 2012 Nov; 23 Suppl 1():S5-9. PubMed ID: 23140347
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Wearable Cardioverter-Defibrillators following Cardiac Surgery-A Single-Center Experience.
    Heimeshoff J; Merz C; Ricklefs M; Kirchhoff F; Haverich A; Bara C; Kühn C
    Thorac Cardiovasc Surg; 2019 Mar; 67(2):92-97. PubMed ID: 29925094
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.